{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:49:55Z","timestamp":1784191795321,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI058810"],"award-info":[{"award-number":["R01 AI058810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5PO1 HL076100"],"award-info":[{"award-number":["5PO1 HL076100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Louisiana Vaccine Center"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.065","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T04:15:40Z","timestamp":1478319340000},"page":"6267-6275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B"],"prefix":"10.1016","volume":"34","author":[{"given":"Guixiang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada F.","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judd E.","family":"Shellito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair J.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.065_b0005","series-title":"Global tuberculosis report 2015","author":"WHO","year":"2015"},{"key":"10.1016\/j.vaccine.2016.10.065_b0010","first-page":"149","article-title":"Age-related tuberculosis incidence and severity in children under 5years of age in Cape Town, South Africa","volume":"14","author":"Moyo","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2016.10.065_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.spid.2005.01.001","article-title":"Current concepts of childhood tuberculosis","volume":"16","author":"Mandalakas","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.065_b0020","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.10.065_b0025","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.10.065_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.10.065_b0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.065_b0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/tropej\/fmn053","article-title":"Disseminated bacillus Calmette-Guerin infection after BCG vaccination","volume":"54","author":"Rezai","year":"2008","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2016.10.065_b0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/IR:22:2-3:177","article-title":"T cell immunity in neonates","volume":"22","author":"Garcia","year":"2000","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2016.10.065_b0050","first-page":"112","article-title":"Development of dendritic cell system","volume":"1","author":"Wu","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/319413a0","article-title":"Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation","volume":"319","author":"Gammon","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.10.065_b0060","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.169.5.1681","article-title":"Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein","volume":"169","author":"Clayton","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.065_b0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007890-199504150-00002","article-title":"Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance","volume":"59","author":"Chen","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2016.10.065_b0070","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.160.9.4217","article-title":"Newborn mice develop balanced Th1\/Th2 primary effector responses in vivo but are biased to Th2 secondary responses","volume":"160","author":"Adkins","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.189.10.1565","article-title":"Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses","volume":"189","author":"McKenzie","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.065_b0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(04)00072-X","article-title":"IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2","volume":"20","author":"Li","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2016.10.065_b0085","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1084\/jem.20071371","article-title":"Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity","volume":"205","author":"Lee","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.065_b0090","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JVI.74.6.2620-2627.2000","article-title":"Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization","volume":"74","author":"Hassett","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0095","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1","article-title":"Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes","volume":"31","author":"Vekemans","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","article-title":"Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies","volume":"105","author":"Hussey","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.10.065_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.1999.tb01341.x","article-title":"Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity","volume":"171","author":"Ramsay","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.10.065_b0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2016.10.065_b0115","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.12.94","article-title":"Prime-boost approaches to tuberculosis vaccine development","volume":"11","author":"Dalmia","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.065_b0120","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.vaccine.2005.05.032","article-title":"Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3","volume":"23","author":"Kent","year":"2005","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2016.10.065_b0125","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2011.01.106","article-title":"A comparative analysis of HIV-specific mucosal\/systemic T cell immunity and avidity following rDNA\/rFPV and poxvirus-poxvirus prime boost immunisations","volume":"29","author":"Ranasinghe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.065_b0130","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2012.02.020","article-title":"CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals","volume":"30","author":"Auten","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.10.065_b0135","doi-asserted-by":"crossref","first-page":"e0148701","DOI":"10.1371\/journal.pone.0148701","article-title":"Flagellin encoded in gene-based vector vaccines is a route-dependent immune adjuvant","volume":"11","author":"Rady","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.065_b0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.065_b0145","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.10.065_b0150","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.065_b0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"D\u2019Souza","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.065_b0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.2007.0648","article-title":"Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis","volume":"27","author":"Chang-hong","year":"2008","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1525-0016(03)00242-9","article-title":"Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses","volume":"8","author":"Sudowe","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.10.065_b0170","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.173.7.4590","article-title":"Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0175","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.168.5.2219","article-title":"Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells","volume":"168","author":"Dadaglio","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0180","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.172.2.1018","article-title":"Development of the dendritic cell system during mouse ontogeny","volume":"172","author":"Dakic","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0185","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1126\/science.271.5256.1723","article-title":"Neonatal tolerance revisited: turning on newborn T cells with dendritic cells","volume":"271","author":"Ridge","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.10.065_b0190","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0264-410X(96)00250-2","article-title":"Induction of cytotoxic T cell responses in newborn mice by DNA immunization","volume":"15","author":"Sarzotti","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.065_b0195","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1073\/pnas.94.16.8726","article-title":"DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life","volume":"94","author":"Martinez","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.10.065_b0200","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1073\/pnas.91.20.9519","article-title":"Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses","volume":"91","author":"Raz","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.10.065_b0205","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.4049\/jimmunol.160.5.2388","article-title":"Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory","volume":"160","author":"Klinman","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni962","article-title":"Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo","volume":"4","author":"Garg","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0215","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.4049\/jimmunol.176.8.4600","article-title":"Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination","volume":"176","author":"Lauterbach","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0220","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.10.065_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/14.1.31","article-title":"Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population","volume":"14","author":"Estcourt","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.065_b0235","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2011.02.010","article-title":"Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells","volume":"29","author":"Derrick","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.065_b0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2016.10.065_b0245","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.10.065_b0250","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.065_b0255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.340.6133.667","article-title":"More woes for struggling HIV vaccine field","volume":"340","author":"Cohen","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2016.10.065_b0260","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T19:34:23Z","timestamp":1692560063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":52,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310131"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}